<?xml version="1.0" encoding="UTF-8"?>
<document id="28079576">
	<sentence id="s1" text="The tumors were characterized by immunohistochemistry for pituitary hormones, cytokeratins, positive regulation of I-kappaB kinase/NF-kappaB signaling, and the neuronal markers regulation of alternative mRNA splicing, via spliceosome, neurofilaments (NFP), and MAP2.">
		<entity id="s1.e1" charOffset="4-10"
			type="HP" text="tumors" ontology_id="HP_0002664"/>
		<entity id="s1.e2" charOffset="92-150"
			type="GO" text="positive regulation of I-kappaB kinase/NF-kappaB signaling" ontology_id="GO_0043123"/>
		<entity id="s1.e3" charOffset="177-233"
			type="GO" text="regulation of alternative mRNA splicing, via spliceosome" ontology_id="GO_0000381"/>
		<pair id="s1.p1" e1="s1.e1"
		    e2="s1.e2" pgr="false"/>
		<pair id="s1.p2" e1="s1.e1"
		    e2="s1.e3" pgr="false"/>
	</sentence>
	<sentence id="s2" text="Double-labeling immunohistochemistry for positive regulation of I-kappaB kinase/NF-kappaB signaling/GH, Pit-1/NFP, Pit-1/MAP2, and regulation of alternative mRNA splicing, via spliceosome/GH was performed in 9/10 tumors.">
		<entity id="s2.e1" charOffset="41-99"
			type="GO" text="positive regulation of I-kappaB kinase/NF-kappaB signaling" ontology_id="GO_0043123"/>
		<entity id="s2.e2" charOffset="131-187"
			type="GO" text="regulation of alternative mRNA splicing, via spliceosome" ontology_id="GO_0000381"/>
		<entity id="s2.e3" charOffset="161-167"
			type="HP" text="tumors" ontology_id="HP_0002664"/>
		<pair id="s2.p1" e1="s2.e1"
		    e2="s2.e3" pgr="false"/>
		<pair id="s2.p2" e1="s2.e2"
		    e2="s2.e3" pgr="false"/>
	</sentence>
</document>
